Clinical Trial Update: ARNI Combined With SGLT2 Inhibitors on Functional Mitral Regurgitation Remodeling

View source ↗

Summary

A completed clinical trial (NCT07379788) is evaluating the combination of an ARNI (sacubitril/valsartan) with SGLT2 inhibitors for remodeling in heart failure w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Mitral Regurgitation
• Heart Failure

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)
• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Rehab Werida | Conditions: Heart Failure | Status: COMPLETED